Previous reports have demonstrated that genetic mechanisms greatly mediate responses to drugs of abuse, including methamphetamine (METH). The circadian gene Period 2 (
Per2
) has been previously associated with differential responses towards METH in mice. While the behavioral consequences of eliminating
Per2
have been illustrated previously,
Per2
overexpression has not yet been comprehensively described; although,
Per2
-overexpressing (
Per2
OE) mice previously showed reduced sensitivity towards METH-induced addiction-like behaviors. To further elucidate this distinct behavior of
Per2
OE mice to METH, we identified possible candidate biomarkers by determining striatal differentially expressed genes (DEGs) in both drug-naïve and METH-treated
Per2
OE mice relative to wild-type (WT), through RNA sequencing. Of the several DEGs in drug naïve
Per2
OE mice, we identified six genes that were altered after repeated METH treatment in WT mice, but not in
Per2
OE mice. These results, validated by quantitative real-time polymerase chain reaction, could suggest that the identified DEGs might underlie the previously reported weaker METH-induced responses of
Per2
OE mice compared to WT. Gene network analysis also revealed that
Asic3
,
Hba-a1
, and
Rnf17
are possibly associated with
Per2
through physical interactions and predicted correlations, and might potentially participate in addiction. Inhibiting the functional protein of
Asic3
prior to METH administration resulted in the partial reduction of METH-induced conditioned place preference in WT mice, supporting a possible involvement of
Asic3
in METH-induced reward. Although encouraging further investigations, our findings suggest that these DEGs, including
Asic3
, may play significant roles in the lower sensitivity of
Per2
OE mice to METH.